Sherwin Criseno speaks to ecancer at UKONS 2019 in Telford about navigating the endocrinopathy puzzle in patients receiving immunotherapy.

Criseno explains that endocrinopathy is poorly understood in the field of immunotherapy due to it being quite rare and the presentation of patients receiving immunotherapy can be vague. He outlines the case study discussed in his session and some of the red flags they managed to recognise.

He also proposes ways for the management of these patients to improve - including education, networking and looking at best practice elsewhere.